Shire plc · Basingstoke, Hampshire United Kingdom (London: SHP)
| Hampshire International Business Park, Chineham | Phone: +44-1256-894-000 |
| Basingstoke, Hampshire | Fax: +44-1256-894-708 |
| RG24 8EP | |
| United Kingdom | 
Map This Company |
Shire plc Rankings
| FTSE 100 |
Company Description
Shire's drugs help patients pay attention and stay on task. The specialty drug company, one of the UK's largest, has a roster that includes attention deficit hyperactivity disorder (ADHD) treatments Vyvanse and Adderall XR. It also makes Pentasa and Lialda, both treatments for ulcerative colitis, as well as drugs for renal diseases and rare genetic disorders like Fabry disease, a genetic disorder. Additional drugs in Shire's portfolio include Carbatrol, a reformulation of a popular epilepsy drug; Alzheimer's disease drug Reminyl; and osteoporosis medication Calcichew. Headquartered in the UK, Shire does most of its business in North America, with sales forces that target specialist physicians.
Shire plc Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 1,839 |
Executives
28 executives listed for Shire plc's Basingstoke, Hampshire location.
| Chairman | Matthew Emmens | |
|---|---|---|
| Deputy Chairman | David Kappler | |
| Vice Chairman | Jeffrey Leiden |